

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 7.57329610 |
| 2 | regulation of T cell chemotaxis (GO:0010819) | 6.49612265 |
| 3 | positive regulation of T cell chemotaxis (GO:0010820) | 6.49612265 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.72575722 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.44469202 |
| 6 | * interferon-gamma production (GO:0032609) | 5.43339467 |
| 7 | lymphocyte chemotaxis (GO:0048247) | 5.38384010 |
| 8 | negative regulation of interleukin-2 production (GO:0032703) | 5.23120481 |
| 9 | regulation of T cell cytokine production (GO:0002724) | 5.15386750 |
| 10 | negative T cell selection (GO:0043383) | 5.14368657 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.05206119 |
| 12 | negative thymic T cell selection (GO:0045060) | 5.00823307 |
| 13 | positive regulation of type 2 immune response (GO:0002830) | 5.00000654 |
| 14 | negative regulation of cytokine production involved in immune response (GO:0002719) | 4.95003569 |
| 15 | positive regulation of transforming growth factor beta production (GO:0071636) | 4.79608143 |
| 16 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.77075991 |
| 17 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.69787160 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.63595959 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.63595959 |
| 20 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.52199203 |
| 21 | T cell migration (GO:0072678) | 4.48968956 |
| 22 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.45427485 |
| 23 | negative regulation of alpha-beta T cell activation (GO:0046636) | 4.33000968 |
| 24 | cellular response to interleukin-15 (GO:0071350) | 4.32639512 |
| 25 | positive regulation of granulocyte differentiation (GO:0030854) | 4.26372008 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.24283263 |
| 27 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 4.24088935 |
| 28 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.19885561 |
| 29 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 4.19882556 |
| 30 | negative regulation of cell killing (GO:0031342) | 4.19642685 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19642685 |
| 32 | response to interleukin-15 (GO:0070672) | 4.17521148 |
| 33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.17417484 |
| 34 | thymic T cell selection (GO:0045061) | 4.16991589 |
| 35 | regulation of activation of Janus kinase activity (GO:0010533) | 4.16836948 |
| 36 | protein K11-linked deubiquitination (GO:0035871) | 4.16794727 |
| 37 | cellular response to interleukin-4 (GO:0071353) | 4.15460078 |
| 38 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 4.12686497 |
| 39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.08855382 |
| 40 | positive regulation of neutrophil migration (GO:1902624) | 4.04719801 |
| 41 | positive regulation of neutrophil chemotaxis (GO:0090023) | 4.04719801 |
| 42 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.03377843 |
| 43 | Peyers patch development (GO:0048541) | 4.03377843 |
| 44 | positive thymic T cell selection (GO:0045059) | 4.01120527 |
| 45 | T cell selection (GO:0045058) | 3.95674445 |
| 46 | leukocyte aggregation (GO:0070486) | 3.94853116 |
| 47 | positive regulation of isotype switching (GO:0045830) | 3.92800108 |
| 48 | positive regulation of immunoglobulin production (GO:0002639) | 3.92129955 |
| 49 | negative regulation of adaptive immune response (GO:0002820) | 3.91625623 |
| 50 | regulation of hypersensitivity (GO:0002883) | 3.90380886 |
| 51 | positive regulation of interleukin-2 production (GO:0032743) | 3.85855951 |
| 52 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.84119330 |
| 53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.81759976 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.80780847 |
| 55 | natural killer cell activation (GO:0030101) | 3.80693637 |
| 56 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.76288550 |
| 57 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.76288550 |
| 58 | positive regulation of T cell migration (GO:2000406) | 3.74257406 |
| 59 | positive T cell selection (GO:0043368) | 3.73138798 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.72603190 |
| 61 | tolerance induction (GO:0002507) | 3.72073111 |
| 62 | positive regulation of B cell differentiation (GO:0045579) | 3.71466376 |
| 63 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.69273005 |
| 64 | positive regulation of T cell mediated immunity (GO:0002711) | 3.69159064 |
| 65 | regulation of interleukin-2 production (GO:0032663) | 3.69013628 |
| 66 | myeloid dendritic cell activation (GO:0001773) | 3.68595972 |
| 67 | regulation of memory T cell differentiation (GO:0043380) | 3.66011959 |
| 68 | activated T cell proliferation (GO:0050798) | 3.65527741 |
| 69 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.64040575 |
| 70 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.63321705 |
| 71 | positive regulation of T cell cytokine production (GO:0002726) | 3.62251563 |
| 72 | myeloid dendritic cell differentiation (GO:0043011) | 3.62095057 |
| 73 | DNA deamination (GO:0045006) | 3.59697801 |
| 74 | positive regulation of B cell mediated immunity (GO:0002714) | 3.59549029 |
| 75 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.59549029 |
| 76 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.58557821 |
| 77 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.55286546 |
| 78 | cellular response to type I interferon (GO:0071357) | 3.52984473 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.52984473 |
| 80 | response to type I interferon (GO:0034340) | 3.52427063 |
| 81 | positive regulation of DNA recombination (GO:0045911) | 3.50150719 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 3.48762603 |
| 83 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.47120261 |
| 84 | regulation of T cell tolerance induction (GO:0002664) | 3.46947709 |
| 85 | response to interleukin-4 (GO:0070670) | 3.46006595 |
| 86 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.44941511 |
| 87 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.43990080 |
| 88 | positive regulation of lymphocyte migration (GO:2000403) | 3.43744320 |
| 89 | mast cell activation (GO:0045576) | 3.41363556 |
| 90 | cellular defense response (GO:0006968) | 3.41139941 |
| 91 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.40751607 |
| 92 | regulation of immunoglobulin production (GO:0002637) | 3.39765194 |
| 93 | regulation of alpha-beta T cell activation (GO:0046634) | 3.38114075 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.37584970 |
| 95 | T cell costimulation (GO:0031295) | 3.36204666 |
| 96 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.36003203 |
| 97 | positive regulation of defense response to virus by host (GO:0002230) | 3.35388060 |
| 98 | positive regulation of interleukin-10 production (GO:0032733) | 3.34787405 |
| 99 | regulation of T cell migration (GO:2000404) | 3.34589706 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33782109 |
| 101 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.33419266 |
| 102 | response to muramyl dipeptide (GO:0032495) | 3.31308135 |
| 103 | lymphocyte costimulation (GO:0031294) | 3.30590777 |
| 104 | mast cell degranulation (GO:0043303) | 3.30095241 |
| 105 | mast cell activation involved in immune response (GO:0002279) | 3.30095241 |
| 106 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.29159810 |
| 107 | regulation of cell killing (GO:0031341) | 3.27792867 |
| 108 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.27263640 |
| 109 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.27263640 |
| 110 | regulation of T-helper 1 type immune response (GO:0002825) | 3.26870593 |
| 111 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.26853411 |
| 112 | alpha-beta T cell activation (GO:0046631) | 3.26016710 |
| 113 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.25826294 |
| 114 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24257796 |
| 115 | positive regulation of humoral immune response (GO:0002922) | 3.23840830 |
| 116 | regulation of chronic inflammatory response (GO:0002676) | 3.23441006 |
| 117 | T-helper cell differentiation (GO:0042093) | 3.23345456 |
| 118 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.23345456 |
| 119 | * positive regulation of interferon-gamma production (GO:0032729) | 3.21028391 |
| 120 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.20195216 |
| 121 | T cell receptor signaling pathway (GO:0050852) | 3.18604316 |
| 122 | angiogenesis involved in wound healing (GO:0060055) | 3.17153703 |
| 123 | T cell activation involved in immune response (GO:0002286) | 3.17095528 |
| 124 | regulation of neutrophil migration (GO:1902622) | 3.16876805 |
| 125 | regulation of neutrophil chemotaxis (GO:0090022) | 3.16876805 |
| 126 | cellular extravasation (GO:0045123) | 3.14884416 |
| 127 | regulation of B cell differentiation (GO:0045577) | 3.14879480 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 3.14834976 |
| 129 | leukocyte cell-cell adhesion (GO:0007159) | 3.14387790 |
| 130 | regulation of T cell mediated immunity (GO:0002709) | 3.14213797 |
| 131 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.13369609 |
| 132 | T cell differentiation involved in immune response (GO:0002292) | 3.13369609 |
| 133 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.13369609 |
| 134 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.13272241 |
| 135 | regulation of B cell mediated immunity (GO:0002712) | 3.12172017 |
| 136 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11520226 |
| 137 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.11418200 |
| 138 | positive regulation of interferon-alpha production (GO:0032727) | 3.09477896 |
| 139 | neutrophil activation (GO:0042119) | 3.09012270 |
| 140 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.08672566 |
| 141 | lymphocyte migration (GO:0072676) | 3.08347140 |
| 142 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.07845321 |
| 143 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.07490109 |
| 144 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.07257283 |
| 145 | alpha-beta T cell differentiation (GO:0046632) | 3.07125085 |
| 146 | positive regulation of macrophage differentiation (GO:0045651) | 3.07074649 |
| 147 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 3.06869624 |
| 148 | cellular response to interferon-beta (GO:0035458) | 3.06492394 |
| 149 | granulocyte activation (GO:0036230) | 3.05288856 |
| 150 | positive regulation of cell killing (GO:0031343) | 3.05219041 |
| 151 | cytidine metabolic process (GO:0046087) | 3.00444462 |
| 152 | cytidine catabolic process (GO:0006216) | 3.00444462 |
| 153 | cytidine deamination (GO:0009972) | 3.00444462 |
| 154 | natural killer cell differentiation (GO:0001779) | 2.95129919 |
| 155 | regulation of type 2 immune response (GO:0002828) | 2.93982837 |
| 156 | iron-sulfur cluster assembly (GO:0016226) | 2.91536158 |
| 157 | metallo-sulfur cluster assembly (GO:0031163) | 2.91536158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.82760748 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.64748988 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.71892601 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.57786894 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.06357576 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.67271974 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.25728999 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.10435730 |
| 9 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.70849816 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.70739962 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32730018 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.21000942 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02679018 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.94546359 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.85284273 |
| 16 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.82165548 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78290628 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72778080 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.58232540 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48823951 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.45233203 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.41532080 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.34002910 |
| 24 | * MAF_26560356_Chip-Seq_TH1_Human | 2.30493178 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.25424544 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12081157 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06369058 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.00668785 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98809129 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89033324 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.87767590 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.82693550 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81971824 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70508408 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70364603 |
| 36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.68957780 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.63502793 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62789423 |
| 39 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.61113392 |
| 40 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58112929 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52770922 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52609735 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.51215006 |
| 44 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.50276515 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49838864 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49064206 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47724194 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47531627 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43170246 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37897607 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36002232 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35711789 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33459579 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30645293 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.30453447 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30452743 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30005100 |
| 58 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.29634118 |
| 59 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29098165 |
| 60 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.28778390 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28235608 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27977013 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27219908 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26638416 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25795374 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25530310 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24698845 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.19088851 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18744718 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17986074 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16227326 |
| 72 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.15759688 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13471500 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12703793 |
| 75 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11958564 |
| 76 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10302999 |
| 77 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.07164947 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07130986 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06265621 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05819845 |
| 81 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04181943 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01731454 |
| 83 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.01708839 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00069300 |
| 85 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99503981 |
| 86 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97853742 |
| 87 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97118314 |
| 88 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96860123 |
| 89 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.96707859 |
| 90 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96655614 |
| 91 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93228823 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93046038 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92841468 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91899536 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91788745 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88389147 |
| 97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.87577206 |
| 98 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87532385 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86507292 |
| 100 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85087940 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85074636 |
| 102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84937470 |
| 103 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.83082322 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82872515 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82812745 |
| 106 | P300_27268052_Chip-Seq_Bcells_Human | 0.82670945 |
| 107 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82288412 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81087070 |
| 109 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.78730285 |
| 110 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.78533075 |
| 111 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.78230593 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77163964 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76663535 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.76663494 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76659052 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76522142 |
| 117 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.75200045 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.74951116 |
| 119 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.74296600 |
| 120 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.74254666 |
| 121 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73561178 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.69747721 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68023734 |
| 124 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.64826381 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.64065369 |
| 126 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.61894803 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61416827 |
| 128 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.60578427 |
| 129 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.60543264 |
| 130 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.60471255 |
| 131 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.59297544 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.59297544 |
| 133 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.57833456 |
| 134 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57505147 |
| 135 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.56119471 |
| 136 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.54937119 |
| 137 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.54734467 |
| 138 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.53800420 |
| 139 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.52254406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.48258525 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.40227708 |
| 3 | MP0009785_altered_susceptibility_to | 3.95098275 |
| 4 | MP0006082_CNS_inflammation | 3.75362264 |
| 5 | MP0003436_decreased_susceptibility_to | 3.36623879 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.35288503 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.26867425 |
| 8 | MP0003763_abnormal_thymus_physiology | 3.22737939 |
| 9 | MP0000685_abnormal_immune_system | 3.22499650 |
| 10 | MP0005387_immune_system_phenotype | 3.15952285 |
| 11 | MP0001790_abnormal_immune_system | 3.15952285 |
| 12 | MP0001800_abnormal_humoral_immune | 3.09941463 |
| 13 | * MP0005025_abnormal_response_to | 2.98364683 |
| 14 | * MP0002723_abnormal_immune_serum | 2.88230360 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.75310396 |
| 16 | * MP0001819_abnormal_immune_cell | 2.68477932 |
| 17 | * MP0002420_abnormal_adaptive_immunity | 2.67246018 |
| 18 | MP0004510_myositis | 2.58246651 |
| 19 | * MP0002419_abnormal_innate_immunity | 2.47032913 |
| 20 | MP0003724_increased_susceptibility_to | 2.37280115 |
| 21 | MP0002405_respiratory_system_inflammati | 2.32582254 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.28260382 |
| 23 | * MP0002398_abnormal_bone_marrow | 2.27407497 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.25083437 |
| 25 | * MP0002006_tumorigenesis | 2.22351744 |
| 26 | MP0003045_fibrosis | 2.19416367 |
| 27 | * MP0000716_abnormal_immune_system | 2.11271644 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.09260143 |
| 29 | MP0004947_skin_inflammation | 2.05752230 |
| 30 | MP0003646_muscle_fatigue | 2.01698911 |
| 31 | MP0001853_heart_inflammation | 1.89812389 |
| 32 | MP0003303_peritoneal_inflammation | 1.85418570 |
| 33 | * MP0001845_abnormal_inflammatory_respons | 1.84092296 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.82182135 |
| 35 | MP0005451_abnormal_body_composition | 1.82123242 |
| 36 | MP0010094_abnormal_chromosome_stability | 1.81444431 |
| 37 | * MP0002722_abnormal_immune_system | 1.81405935 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.79997261 |
| 39 | * MP0003448_altered_tumor_morphology | 1.77438210 |
| 40 | MP0000858_altered_metastatic_potential | 1.76197420 |
| 41 | MP0001873_stomach_inflammation | 1.75086574 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.73538978 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.72635168 |
| 44 | * MP0002429_abnormal_blood_cell | 1.67422087 |
| 45 | * MP0005310_abnormal_salivary_gland | 1.63684879 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.58815950 |
| 47 | MP0002933_joint_inflammation | 1.53661770 |
| 48 | MP0001851_eye_inflammation | 1.47887883 |
| 49 | MP0008058_abnormal_DNA_repair | 1.45835626 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.44706620 |
| 51 | MP0003866_abnormal_defecation | 1.41635137 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.39899343 |
| 53 | MP0002163_abnormal_gland_morphology | 1.38815491 |
| 54 | MP0009764_decreased_sensitivity_to | 1.35161030 |
| 55 | MP0002009_preneoplasia | 1.34566535 |
| 56 | * MP0008469_abnormal_protein_level | 1.34422397 |
| 57 | MP0004381_abnormal_hair_follicle | 1.31584648 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.30679376 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.30679376 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.29780264 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.28007997 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.25601661 |
| 63 | MP0000490_abnormal_crypts_of | 1.25046641 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.24091391 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.21848653 |
| 66 | MP0009278_abnormal_bone_marrow | 1.20395908 |
| 67 | MP0008057_abnormal_DNA_replication | 1.17889692 |
| 68 | MP0003786_premature_aging | 1.17709097 |
| 69 | MP0002132_abnormal_respiratory_system | 1.16628495 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.12487220 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 1.09044829 |
| 72 | MP0001661_extended_life_span | 1.06598623 |
| 73 | MP0008872_abnormal_physiological_respon | 1.02214972 |
| 74 | MP0001501_abnormal_sleep_pattern | 1.00991792 |
| 75 | MP0000013_abnormal_adipose_tissue | 0.96431984 |
| 76 | MP0000343_altered_response_to | 0.96294849 |
| 77 | MP0004043_abnormal_pH_regulation | 0.94359705 |
| 78 | MP0001348_abnormal_lacrimal_gland | 0.92567748 |
| 79 | MP0009763_increased_sensitivity_to | 0.88080871 |
| 80 | MP0001919_abnormal_reproductive_system | 0.87080237 |
| 81 | * MP0002019_abnormal_tumor_incidence | 0.86985551 |
| 82 | MP0003693_abnormal_embryo_hatching | 0.83123001 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.82843421 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.82574212 |
| 85 | MP0009697_abnormal_copulation | 0.81848754 |
| 86 | MP0003111_abnormal_nucleus_morphology | 0.78524315 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.77944891 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.76231792 |
| 89 | MP0006035_abnormal_mitochondrial_morpho | 0.75770008 |
| 90 | MP0005390_skeleton_phenotype | 0.75527915 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.74953009 |
| 92 | MP0004142_abnormal_muscle_tone | 0.73772920 |
| 93 | MP0002254_reproductive_system_inflammat | 0.73478669 |
| 94 | MP0005166_decreased_susceptibility_to | 0.73245050 |
| 95 | MP0010307_abnormal_tumor_latency | 0.71469920 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.70409886 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.67001974 |
| 98 | MP0001346_abnormal_lacrimal_gland | 0.66360231 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 0.66227141 |
| 100 | MP0004130_abnormal_muscle_cell | 0.65871809 |
| 101 | MP0008873_increased_physiological_sensi | 0.65438432 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.64478705 |
| 103 | MP0003172_abnormal_lysosome_physiology | 0.64166702 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.63996976 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 0.63827288 |
| 106 | MP0000015_abnormal_ear_pigmentation | 0.63351465 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.63010032 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.63007437 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.62295826 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.61959858 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.61181677 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.59257281 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.59093435 |
| 114 | MP0001663_abnormal_digestive_system | 0.56698347 |
| 115 | MP0000313_abnormal_cell_death | 0.55166235 |
| 116 | MP0003795_abnormal_bone_structure | 0.55141815 |
| 117 | MP0001764_abnormal_homeostasis | 0.54764291 |
| 118 | MP0001270_distended_abdomen | 0.54722043 |
| 119 | MP0002970_abnormal_white_adipose | 0.53352107 |
| 120 | MP0000627_abnormal_mammary_gland | 0.53109769 |
| 121 | MP0003828_pulmonary_edema | 0.53043223 |
| 122 | MP0003091_abnormal_cell_migration | 0.52310493 |
| 123 | MP0005389_reproductive_system_phenotype | 0.51692157 |
| 124 | MP0002083_premature_death | 0.50863914 |
| 125 | MP0005410_abnormal_fertilization | 0.50654752 |
| 126 | MP0005647_abnormal_sex_gland | 0.49910816 |
| 127 | MP0000358_abnormal_cell_content/ | 0.49713738 |
| 128 | MP0000383_abnormal_hair_follicle | 0.49675974 |
| 129 | MP0002095_abnormal_skin_pigmentation | 0.49575011 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.48944588 |
| 131 | MP0002693_abnormal_pancreas_physiology | 0.47351865 |
| 132 | * MP0002136_abnormal_kidney_physiology | 0.46591037 |
| 133 | MP0000604_amyloidosis | 0.44693534 |
| 134 | MP0003136_yellow_coat_color | 0.44074906 |
| 135 | MP0000367_abnormal_coat/_hair | 0.42607271 |
| 136 | MP0000249_abnormal_blood_vessel | 0.42070197 |
| 137 | MP0003077_abnormal_cell_cycle | 0.41228462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.99900995 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.51857067 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.23391118 |
| 4 | Stomatitis (HP:0010280) | 5.23345072 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.93940300 |
| 6 | * Myositis (HP:0100614) | 4.80508912 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.75444886 |
| 8 | T lymphocytopenia (HP:0005403) | 4.62412364 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.61082748 |
| 10 | * Optic neuritis (HP:0100653) | 4.36218129 |
| 11 | * Retrobulbar optic neuritis (HP:0100654) | 4.36218129 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.31373997 |
| 13 | Nasal polyposis (HP:0100582) | 4.28740752 |
| 14 | Chronic otitis media (HP:0000389) | 4.14492195 |
| 15 | * Orchitis (HP:0100796) | 4.13474990 |
| 16 | Autoimmune hemolytic anemia (HP:0001890) | 4.03014986 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.00330953 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 4.00330953 |
| 19 | Recurrent viral infections (HP:0004429) | 3.97958687 |
| 20 | Increased IgM level (HP:0003496) | 3.92800775 |
| 21 | Agammaglobulinemia (HP:0004432) | 3.85686762 |
| 22 | Abnormality of T cells (HP:0002843) | 3.70909398 |
| 23 | * Vasculitis (HP:0002633) | 3.68419082 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 3.68299092 |
| 25 | Abnormality of lateral ventricle (HP:0030047) | 3.67211496 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.63690251 |
| 27 | Recurrent skin infections (HP:0001581) | 3.57489993 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.55965622 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.49083752 |
| 30 | Obstructive lung disease (HP:0006536) | 3.42866150 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.42866150 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 3.42264232 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 3.40308703 |
| 34 | Recurrent bronchitis (HP:0002837) | 3.36899782 |
| 35 | * Meningitis (HP:0001287) | 3.27000391 |
| 36 | Abnormality of the labia minora (HP:0012880) | 3.24727035 |
| 37 | IgM deficiency (HP:0002850) | 3.23737054 |
| 38 | Combined immunodeficiency (HP:0005387) | 3.20468573 |
| 39 | Joint swelling (HP:0001386) | 3.20410438 |
| 40 | IgG deficiency (HP:0004315) | 3.16824996 |
| 41 | Congenital stationary night blindness (HP:0007642) | 3.12174068 |
| 42 | Hypoplastic ischia (HP:0003175) | 3.11624247 |
| 43 | Leukocytosis (HP:0001974) | 3.09204609 |
| 44 | Prominent nose (HP:0000448) | 3.07403500 |
| 45 | Eosinophilia (HP:0001880) | 3.05704879 |
| 46 | Gastrointestinal infarctions (HP:0005244) | 2.99897499 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.94902410 |
| 48 | Chronic diarrhea (HP:0002028) | 2.94314185 |
| 49 | Abnormality of eosinophils (HP:0001879) | 2.93736990 |
| 50 | Prostate neoplasm (HP:0100787) | 2.90855493 |
| 51 | Cheilitis (HP:0100825) | 2.88237505 |
| 52 | Gingivitis (HP:0000230) | 2.84179545 |
| 53 | * Encephalitis (HP:0002383) | 2.84109134 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.83851435 |
| 55 | * Pulmonary infiltrates (HP:0002113) | 2.82647595 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.81974720 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.78190600 |
| 58 | * Hemoptysis (HP:0002105) | 2.78011184 |
| 59 | Thyroiditis (HP:0100646) | 2.76001864 |
| 60 | Abnormality of the prostate (HP:0008775) | 2.73762901 |
| 61 | Dyschromatopsia (HP:0007641) | 2.72629080 |
| 62 | Slow saccadic eye movements (HP:0000514) | 2.70675772 |
| 63 | Poikiloderma (HP:0001029) | 2.70413192 |
| 64 | Cutaneous melanoma (HP:0012056) | 2.70140778 |
| 65 | Granulocytopenia (HP:0001913) | 2.69809783 |
| 66 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.69662828 |
| 67 | Type I transferrin isoform profile (HP:0003642) | 2.67519030 |
| 68 | Petechiae (HP:0000967) | 2.66614830 |
| 69 | Pustule (HP:0200039) | 2.65015166 |
| 70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.64291827 |
| 71 | Sparse scalp hair (HP:0002209) | 2.64148912 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.62097642 |
| 73 | B lymphocytopenia (HP:0010976) | 2.62097642 |
| 74 | IgA deficiency (HP:0002720) | 2.59749829 |
| 75 | Lymphopenia (HP:0001888) | 2.57553247 |
| 76 | Basal ganglia calcification (HP:0002135) | 2.52950281 |
| 77 | Periodontitis (HP:0000704) | 2.49549938 |
| 78 | 3-Methylglutaconic aciduria (HP:0003535) | 2.48000865 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.47630020 |
| 80 | Abnormal protein glycosylation (HP:0012346) | 2.47380861 |
| 81 | Abnormal glycosylation (HP:0012345) | 2.47380861 |
| 82 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.47380861 |
| 83 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.47380861 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.45190855 |
| 85 | * Keratoconjunctivitis sicca (HP:0001097) | 2.45150201 |
| 86 | Fetal akinesia sequence (HP:0001989) | 2.45004873 |
| 87 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.44292176 |
| 88 | Increased IgE level (HP:0003212) | 2.44033822 |
| 89 | Abnormality of the ischium (HP:0003174) | 2.42263845 |
| 90 | Attenuation of retinal blood vessels (HP:0007843) | 2.42027023 |
| 91 | Basal cell carcinoma (HP:0002671) | 2.40351237 |
| 92 | Gingival bleeding (HP:0000225) | 2.38009186 |
| 93 | Squamous cell carcinoma (HP:0002860) | 2.37852109 |
| 94 | * Arterial thrombosis (HP:0004420) | 2.36816889 |
| 95 | Colitis (HP:0002583) | 2.30299843 |
| 96 | Cerebral hypomyelination (HP:0006808) | 2.28498648 |
| 97 | Lymphoma (HP:0002665) | 2.27821418 |
| 98 | Cellulitis (HP:0100658) | 2.27159453 |
| 99 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.26974604 |
| 100 | Thrombocytosis (HP:0001894) | 2.26406988 |
| 101 | * Keratoconjunctivitis (HP:0001096) | 2.25707623 |
| 102 | Villous atrophy (HP:0011473) | 2.24544919 |
| 103 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.24544919 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 2.24297748 |
| 105 | Central scotoma (HP:0000603) | 2.23382998 |
| 106 | Spontaneous hematomas (HP:0007420) | 2.22982163 |
| 107 | Horizontal nystagmus (HP:0000666) | 2.21458448 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 2.20925812 |
| 109 | Acute myeloid leukemia (HP:0004808) | 2.17186642 |
| 110 | * Gangrene (HP:0100758) | 2.16974749 |
| 111 | Impaired smooth pursuit (HP:0007772) | 2.12858699 |
| 112 | Hypoproteinemia (HP:0003075) | 2.12795672 |
| 113 | Microvesicular hepatic steatosis (HP:0001414) | 2.12590341 |
| 114 | Generalized hypopigmentation of hair (HP:0011358) | 2.11840930 |
| 115 | Recurrent pneumonia (HP:0006532) | 2.10458970 |
| 116 | Fair hair (HP:0002286) | 2.07194955 |
| 117 | Chronic sinusitis (HP:0011109) | 2.05701944 |
| 118 | Abnormality of DNA repair (HP:0003254) | 2.05442288 |
| 119 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.04133712 |
| 120 | Chest pain (HP:0100749) | 2.03280768 |
| 121 | * Arthralgia (HP:0002829) | 2.02875475 |
| 122 | Urticaria (HP:0001025) | 2.02546082 |
| 123 | Menstrual irregularities (HP:0000858) | 2.01106185 |
| 124 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98964219 |
| 125 | Recurrent sinusitis (HP:0011108) | 1.97856698 |
| 126 | Epistaxis (HP:0000421) | 1.96848467 |
| 127 | Hypochromic anemia (HP:0001931) | 1.96812177 |
| 128 | Muscle stiffness (HP:0003552) | 1.96635085 |
| 129 | Hepatic necrosis (HP:0002605) | 1.95927759 |
| 130 | Skin ulcer (HP:0200042) | 1.95590307 |
| 131 | Alveolar cell carcinoma (HP:0006519) | 1.95108275 |
| 132 | Amniotic constriction ring (HP:0009775) | 1.94779574 |
| 133 | Abnormality of placental membranes (HP:0011409) | 1.94779574 |
| 134 | Dysautonomia (HP:0002459) | 1.93808102 |
| 135 | Hypoplasia of the thymus (HP:0000778) | 1.93801717 |
| 136 | Prolonged bleeding time (HP:0003010) | 1.92103322 |
| 137 | Viral hepatitis (HP:0006562) | 1.90549851 |
| 138 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.89372155 |
| 139 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85269480 |
| 140 | Bronchitis (HP:0012387) | 1.84981208 |
| 141 | Lower limb hyperreflexia (HP:0002395) | 1.82663512 |
| 142 | * Abnormality of the endocardium (HP:0004306) | 1.82363584 |
| 143 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.82171259 |
| 144 | Thick nail (HP:0001805) | 1.81755645 |
| 145 | * Keratitis (HP:0000491) | 1.80126338 |
| 146 | Leukopenia (HP:0001882) | 1.79040850 |
| 147 | Ileus (HP:0002595) | 1.78051028 |
| 148 | Abnormality of the periventricular white matter (HP:0002518) | 1.77581766 |
| 149 | Recurrent lower respiratory tract infections (HP:0002783) | 1.77420473 |
| 150 | Chronic hepatic failure (HP:0100626) | 1.75174445 |
| 151 | Hyperlipoproteinemia (HP:0010980) | 1.73514471 |
| 152 | Stomach cancer (HP:0012126) | 1.72273218 |
| 153 | Gaze-evoked nystagmus (HP:0000640) | 1.71207597 |
| 154 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.69550741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.34210219 |
| 2 | MAP4K1 | 4.17848942 |
| 3 | MAP3K14 | 3.61745914 |
| 4 | JAK3 | 3.54011889 |
| 5 | TYK2 | 3.38537412 |
| 6 | FRK | 2.79645093 |
| 7 | IKBKE | 2.65526840 |
| 8 | ITK | 2.54056643 |
| 9 | TBK1 | 2.52169151 |
| 10 | JAK1 | 2.40673066 |
| 11 | KIT | 2.28165463 |
| 12 | IRAK4 | 2.21175400 |
| 13 | IKBKB | 2.16500091 |
| 14 | FGFR4 | 2.11458799 |
| 15 | MST4 | 2.08101567 |
| 16 | BLK | 1.99776788 |
| 17 | SRPK1 | 1.98037747 |
| 18 | PIK3CG | 1.96107307 |
| 19 | ZAP70 | 1.93475757 |
| 20 | IRAK3 | 1.92613711 |
| 21 | STK10 | 1.83418417 |
| 22 | TEC | 1.69356632 |
| 23 | FGFR3 | 1.67929388 |
| 24 | CHUK | 1.65242147 |
| 25 | BTK | 1.57729171 |
| 26 | SYK | 1.56146737 |
| 27 | LCK | 1.56006639 |
| 28 | CSK | 1.55357448 |
| 29 | EIF2AK3 | 1.51299305 |
| 30 | PIM2 | 1.50442534 |
| 31 | BMPR2 | 1.48166479 |
| 32 | HCK | 1.45110279 |
| 33 | PIM1 | 1.37003615 |
| 34 | VRK2 | 1.34524377 |
| 35 | SIK2 | 1.32417380 |
| 36 | MAP3K13 | 1.30408047 |
| 37 | CAMKK2 | 1.29734133 |
| 38 | NLK | 1.26682148 |
| 39 | SIK3 | 1.25111688 |
| 40 | EEF2K | 1.22032084 |
| 41 | RIPK4 | 1.20353669 |
| 42 | NEK9 | 1.17137099 |
| 43 | EPHA3 | 1.14361012 |
| 44 | KDR | 1.13740389 |
| 45 | MAP3K12 | 1.09951477 |
| 46 | GRK7 | 1.09506223 |
| 47 | FES | 1.08938773 |
| 48 | PRKCQ | 1.06737166 |
| 49 | PINK1 | 1.04710298 |
| 50 | JAK2 | 1.04346288 |
| 51 | EPHB1 | 1.04251072 |
| 52 | NME1 | 1.04206059 |
| 53 | NME2 | 1.03307248 |
| 54 | ADRBK2 | 1.01962193 |
| 55 | LYN | 0.99068150 |
| 56 | TAOK3 | 0.89200907 |
| 57 | MARK3 | 0.89187479 |
| 58 | TGFBR2 | 0.85687472 |
| 59 | RPS6KA4 | 0.84751982 |
| 60 | ZAK | 0.84470080 |
| 61 | GRK6 | 0.82419450 |
| 62 | DAPK1 | 0.81340599 |
| 63 | BCKDK | 0.80642458 |
| 64 | CDK12 | 0.79665589 |
| 65 | TRPM7 | 0.75445440 |
| 66 | PRPF4B | 0.75024867 |
| 67 | CDK4 | 0.74611552 |
| 68 | BRD4 | 0.74033998 |
| 69 | TNK2 | 0.73524139 |
| 70 | IRAK1 | 0.73369115 |
| 71 | NUAK1 | 0.72689444 |
| 72 | WNK3 | 0.71979239 |
| 73 | CSF1R | 0.70989863 |
| 74 | MAP3K7 | 0.68923417 |
| 75 | FGR | 0.68893328 |
| 76 | STK4 | 0.66478815 |
| 77 | MAPK7 | 0.65188553 |
| 78 | STK24 | 0.64630493 |
| 79 | NEK1 | 0.62637339 |
| 80 | ALK | 0.62504422 |
| 81 | CDK9 | 0.62145978 |
| 82 | RIPK1 | 0.61392819 |
| 83 | PBK | 0.60021872 |
| 84 | OBSCN | 0.58007343 |
| 85 | PRKCH | 0.56896067 |
| 86 | MAPK12 | 0.54419017 |
| 87 | CAMKK1 | 0.53818505 |
| 88 | CLK1 | 0.53465158 |
| 89 | CDK6 | 0.51206705 |
| 90 | RPS6KA5 | 0.48538552 |
| 91 | MAP3K10 | 0.48105343 |
| 92 | RAF1 | 0.46806257 |
| 93 | EIF2AK2 | 0.46472411 |
| 94 | MAPKAPK2 | 0.46049467 |
| 95 | NEK2 | 0.45048974 |
| 96 | MAPK11 | 0.44172151 |
| 97 | LRRK2 | 0.43561596 |
| 98 | SCYL2 | 0.42802499 |
| 99 | FLT3 | 0.41555580 |
| 100 | PDK1 | 0.41256088 |
| 101 | ABL1 | 0.40170326 |
| 102 | HIPK2 | 0.39702113 |
| 103 | YES1 | 0.38191958 |
| 104 | MATK | 0.37790977 |
| 105 | WNK4 | 0.34481300 |
| 106 | BMX | 0.34378587 |
| 107 | MELK | 0.33278164 |
| 108 | MAP2K3 | 0.32210086 |
| 109 | EGFR | 0.32204398 |
| 110 | PRKCD | 0.31844610 |
| 111 | RPS6KB2 | 0.31628410 |
| 112 | MAP3K1 | 0.31376815 |
| 113 | TESK2 | 0.30755448 |
| 114 | ERN1 | 0.29657571 |
| 115 | MAPK13 | 0.29000925 |
| 116 | MAP3K5 | 0.28358863 |
| 117 | ATR | 0.28187348 |
| 118 | DMPK | 0.28171725 |
| 119 | IGF1R | 0.28006414 |
| 120 | CDK19 | 0.27577147 |
| 121 | TSSK6 | 0.27096908 |
| 122 | MAPKAPK3 | 0.24925691 |
| 123 | FER | 0.24768400 |
| 124 | FYN | 0.23447539 |
| 125 | TLK1 | 0.23332754 |
| 126 | PIK3CA | 0.22166852 |
| 127 | MAP3K3 | 0.21872446 |
| 128 | MAP3K11 | 0.19833912 |
| 129 | RPS6KA6 | 0.18602371 |
| 130 | MAP2K6 | 0.17826263 |
| 131 | MAPK3 | 0.17496489 |
| 132 | STK3 | 0.17087451 |
| 133 | GSK3A | 0.15594349 |
| 134 | MAP3K8 | 0.14671720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.23659351 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.90454087 |
| 3 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.32764224 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.92483964 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.81253495 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.73404295 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.65952252 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63527948 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58802538 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.46892567 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35746579 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.27854633 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.21103752 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.15913393 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.14235936 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12054812 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06106960 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04771963 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89835202 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86879810 |
| 21 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.83135793 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78832927 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.68528998 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.66608254 |
| 25 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.59011873 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57794995 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.56753715 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.53982081 |
| 29 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.53680513 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.53231977 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.51820878 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51803365 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47416257 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.42782571 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.42132531 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39048368 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.36081105 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31276496 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31027334 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29385971 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.23986893 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.19563058 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16654374 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15514019 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.11317923 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.08053232 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.07190338 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.03735750 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02349681 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98640430 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98391375 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.93154220 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.93036094 |
| 54 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92043812 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90347412 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88815947 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87619991 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.84906552 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83694308 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.83059632 |
| 61 | Mismatch repair_Homo sapiens_hsa03430 | 0.82233107 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79300946 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79002147 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77923728 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77001171 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75776541 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75774453 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72832210 |
| 69 | RNA transport_Homo sapiens_hsa03013 | 0.72311309 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71448498 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.69618976 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.65542909 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65526793 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65141371 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65136786 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64762463 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60108237 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59251494 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.54992143 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54805674 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51405128 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50778155 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50738497 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49812374 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49342881 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48977462 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48177301 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48097819 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47117788 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44618228 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43515855 |
| 92 | Homologous recombination_Homo sapiens_hsa03440 | 0.42581109 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41608177 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41528764 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40843098 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39569900 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38224681 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37591662 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36702909 |
| 100 | DNA replication_Homo sapiens_hsa03030 | 0.35698851 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34462483 |
| 102 | Phototransduction_Homo sapiens_hsa04744 | 0.34418725 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.34105878 |
| 104 | Salivary secretion_Homo sapiens_hsa04970 | 0.33822153 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.33511132 |
| 106 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33410092 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32785795 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32628098 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31079531 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30300290 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29862272 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.28857878 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28158020 |
| 114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28103399 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.27775433 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25524530 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22898797 |
| 118 | Base excision repair_Homo sapiens_hsa03410 | 0.21910241 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21705383 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.21073446 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.20884710 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.19841264 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.17876432 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17001840 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.16568542 |
| 126 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16445990 |
| 127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16060912 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15405027 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14715608 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14353593 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13739818 |
| 132 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.12533667 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.11957112 |
| 134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09565351 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09405268 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.09254737 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.08567875 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08544999 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07755053 |

